International Cannabis Weekly: 364

CZECH CANNABIS BILL STALLS BUT HOPE REMAINS FOR FULL LEGALISATION

The Czech Republic’s cannabis legalisation project remains stuck in political and legislative limbo, as the rumour mill surrounding its future moves into overdrive.

READ MORE  »

U.S. RESCHEDULING DELAY SENDS CANNABIS STOCKS INTO A TAILSPIN

READ MORE »

CALLS TO RESTRICT MEDICAL CANNABIS PRESCRIPTIONS IN GERMANY GROW

READ MORE »

• Jazz fails Phase 3 trial, BAT set to see growth from cannabis investment, and DanCann Pharma reports first profit.
• A new study of endometriosis patients in Europe finds cannabis has a significant impact on wellbeing and quality of life.
• The UK needs to fund research on medical cannabis and ADHD, says Welford pharmacist prescriber.
• Grounding of British Airways flight sparks calls for more medical cannabis education.
• Brains Bioceutical set to achieve one of the world’s first CEP for cannabidiol certification.
• Dalgety granted a Home Office licence to supply in the UK alongside a full EU-GMP certification.

GET EARLY BIRD TICKETS »

• Cannabis rescheduling unlikely to improve banking access for state-legal cannabis businesses, researchers say.
• U.S. cannabis licence application rates are up for the first time in two years, new report finds.
• New Wana Brands marketplace brings together Martha Stewart CBD, Charlotte’s Web, and Cann products.
• Political fight among Missouri Republicans halts ban on intoxicating hemp products.
• Nevada awards cannabis lounge licences; less than half of the social equity licences allocated.
• Home Depot will stop testing workers for cannabis and limit drug screening for most employees.

• Canadian cannabis sales continue turbulent year with 2% downturn in June, 2024.
• Quebec cannabis seller opens 100th store, with more store openings planned for the coming year.
• SNDL has been chosen as the successful bid in the acquisition of the Indiva business and assets, subject to approval.
• Tokyo Smoke is closing 29 locations as part of a major restructuring as the retailer seeks creditor protection.
• Alberta becomes third Canadian province to allow cannabis deliveries via Uber Eats.
• Entourage Health reports second quarter 2024 financial results, with ‘solid  momentum year over year’.

• Colombia’s cannabis exports expand as President Petro presses Congress to legalise adult-use cannabis.
• Advances in the regulation of medicinal cannabis in Brazil highlighted in Alepe meeting.
• UFSC launches TV programme to democratise access to information on cannabis.
• Patient with panic disorder and generalised anxiety disorder granted habeas corpus in Pernambuco.

• Profits quadruple for medicinal cannabis grower ECS Botanics after record harvest.
• Mater plans next round of medicinal cannabis trials for palliative care patients in Australia.
• Australian cultivator and research firm Biolife Group has acquired a 20% stake in AHA Corporate.
• Breathe Life Sciences has manufactured and delivered Australia’s first pharmaceutical-grade cannabis pastilles.

• Israeli cannabis company Intercure partners with Cookies to launch cannabis pharmacies in Germany.
• Commercialisation of hemp lags in Zimbabwe despite established laws and regulations.